1 min read

New Data Shows MR CLEAN Trial Results Extend to at Least Two Years

New Data Shows MR CLEAN Trial Results Extend to at Least Two Years

stent-403500-edited.png

“I think it will help you as a doctor to know you’re doing a treatment not only for 3 months, but that the treatment benefit is going to last for at least 2 years,” said Yvo Roos, MD. “It’s going to help you be more convincing to the relatives that you’re doing the right thing, that you’re doing something that’s really going to help them."

The above quote is in reference to new long-term followup data published as of April 6th, 2017, which now confirms and extends the outcomes of the MR CLEAN endovascular therapy trial in acute ischemic stroke patients.  The results show that 1 out of every 3 patients treated with catheter based intervention are returning home to care for themselves within 3 months and these results are durable up to 2 years! Read the full details of the follow up data right here

LEARN ABOUT PULSARA

Pulsara Around the World - July 2025

Pulsara Around the World - July 2025

June Recap Celebrating Customer and Community Successes In Colorado Teams in Colorado Springs, CO, are using Pulsara to keep STEMI DTB times under 30...

Read More >>
When Every Second Counts

When Every Second Counts

How Metropolitan EMS and Baptist Health Medical Center worked together to achieve a remarkable outcome for one stroke patient When a woman in Little...

Read More >>
Stronger Together: How One Colorado Springs Hospital Is Uniting Regional Emergency Care

Stronger Together: How One Colorado Springs Hospital Is Uniting Regional Emergency Care

UCHealth Memorial Hospital is Using Pulsara to Facilitate Feedback, Education, and Better Outcomes Across Organizations What if the future of...

Read More >>